Medicare AdvantageCoverageMedium impact
MA06.025s, Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments
Independence Blue Cross·Pain Management, Psychiatry, Family Medicine +1 more·Pharmacy
Effective date
Jun 5, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.025s has been updated with changes to coverage, medical necessity criteria, and billing codes for presumptive and definitive drug testing in substance abuse and pain management treatments. This affects both reimbursement positions and coding guidelines for drug testing procedures.
Action Required
By June 5, 2026: Billing team must review and implement updated coverage criteria and coding guidelines for presumptive and definitive drug testing procedures used in substance abuse and pain management. Update billing system rules and encounter forms to reflect new medical necessity requirements. Verify coding accuracy for drug testing claims to avoid denials under the revised policy.